Greenyn Biotechnology Co., Ltd (6846.TWO)

TWD 77.8

(0.0%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 800.51 Million 705.3 Million 693.76 Million 662.55 Million -
Cost of Revenue 408.05 Million 334.37 Million 335.74 Million 323.65 Million -
Gross Profit 392.45 Million 370.92 Million 358.01 Million 338.9 Million -
Operating Expenses 220.39 Million 204.24 Million 188.89 Million 179.26 Million 129.69 Million
Selling, General and Administrative Expenses 164.15 Million 146.81 Million 136.43 Million 146.87 Million -
Research and Development Expenses 56.24 Million 57.42 Million 52.46 Million 32.38 Million -
Other Expenses - 17.35 Million 974 Thousand -1.04 Million 129.69 Million
Cost and Expenses 640.69 Million 538.62 Million 524.64 Million 502.91 Million 129.69 Million
Operating Income 159.81 Million 185.25 Million 170.38 Million 159.64 Million 129.69 Million
Interest Expense 1.65 Million 1.24 Million 1.36 Million 1.74 Million 3.17 Million
Income Tax Expense 35.16 Million 37.27 Million 36.24 Million 33.58 Million -
Earnings before Tax 165.83 Million 184 Million 169.02 Million 157.12 Million -
Net Income 130.66 Million 146.73 Million 132.77 Million 123.54 Million -
Earnings Per Share Basic 5.04 6.01 5.46 5.35 -
Earnings Per Share Diluted 4.99 5.93 5.21 5.16 -
Weighted Average Shares Outstanding 25.91 Million 24.41 Million 24.31 Million 23.1 Million 23.1 Million
Weighted Average Shares Outstanding (Diluted) 26.18 Million 24.74 Million 25.49 Million 23.95 Million 23.95 Million
Gross Margin 0.49 0.53 0.52 0.51 -
EBIT Margin 0.24 0.30 0.28 0.28 -
Profit Margin 0.16 0.21 0.19 0.19 -
EBITDA 192.4 Million 210.39 Million 193.67 Million 187.54 Million 160.68 Million
Earnings Before Tax Margin 0.20 0.26 0.25 0.24 -

Income Statement Charts